Moreover, GLS1 and GLS2 are considered as independent prognostic factors for HCC, with GLS2 negatively correlated to tumor stage and overall survival, possibly for its anti-proliferative effects as a result of blocking G2/M phases of the cell cycle. This evidence concerns the gene GLS2 and hepatocellular carcinoma.